Related Experiment Video
Updated: May 24, 2025

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Lipotoxicity as a therapeutic target in the type 2 diabetic heart
Trang Van T Luong1, Seonbu Yang1, Jaetaek Kim1
1Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
Abstract:
Cardiac lipotoxicity, characterized by excessive lipid accumulation in the cardiac tissue, is a critical contributor to the pathogenesis of diabetic heart. Recent research has highlighted the key mechanisms underlying lipotoxicity, including mitochondrial dysfunction, endoplasmic reticulum stress, inflammation, and cell apoptosis, which ultimately impair the cardiac function. Various therapeutic interventions have been developed to target these pathways, mitigate lipotoxicity, and improve cardiovascular outcomes in diabetic patients. Given the global escalation in the prevalence of diabetes and the urgent demand for effective therapeutic approaches, this review focuses on how targeting cardiac lipotoxicity may be a promising avenue for treating diabetes.
Insights
Excessive lipid buildup in the heart (cardiac lipotoxicity) worsens diabetic heart disease. Targeting this condition offers a promising therapeutic strategy for managing diabetes and improving heart health.
Area of Science:
- Cardiovascular Science
- Metabolic Disease Research
- Molecular Cardiology
Background:
- Diabetic heart disease is a major complication of diabetes mellitus.
- Cardiac lipotoxicity, excessive lipid accumulation in heart tissue, is a key driver of diabetic cardiomyopathy.
- Mechanisms include mitochondrial dysfunction, endoplasmic reticulum stress, inflammation, and apoptosis, leading to impaired cardiac function.
Purpose of the Study:
- To review the mechanisms of cardiac lipotoxicity in diabetes.
- To explore therapeutic strategies targeting cardiac lipotoxicity.
- To highlight the potential of targeting cardiac lipotoxicity for diabetes treatment.
Main Methods:
- Literature review of recent research on cardiac lipotoxicity and diabetes.
- Analysis of key molecular and cellular pathways involved.
- Evaluation of current and potential therapeutic interventions.
Main Results:
- Cardiac lipotoxicity involves mitochondrial dysfunction, ER stress, inflammation, and apoptosis.
- These pathways contribute to impaired cardiac function in diabetic patients.
- Therapeutic interventions targeting these mechanisms show promise.
Conclusions:
- Targeting cardiac lipotoxicity is a viable therapeutic strategy for diabetic heart disease.
- Further research is needed to develop effective treatments.
- Mitigating cardiac lipotoxicity may improve cardiovascular outcomes in diabetic individuals.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational

